Strata Critical Medical (SRTA) Operating Leases (2020 - 2026)

Strata Critical Medical (SRTA) has 7 years of Operating Leases data on file, last reported at $3.5 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $3.5 million, down 38.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (down 38.99% YoY), and the FY2025 annual result was $2.7 million, up 13.66% from the prior year.
• Operating Leases advanced to $3.5 million in Q1 2026 per SRTA's latest filing, from $2.7 million in the prior quarter.
• Over five years, Operating Leases peaked at $23.7 million in Q3 2024 and troughed at $962000.0 in Q1 2022.
• A 5-year average of $11.7 million and a median of $14.5 million in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2022 and 2024: Operating Leases surged 5284.89% in 2022, then slumped 88.16% in 2024.
• A 5-year view of Operating Leases shows it stood at $15.0 million in 2022, then soared by 31.85% to $19.7 million in 2023, then tumbled by 88.16% to $2.3 million in 2024, then climbed by 13.66% to $2.7 million in 2025, then soared by 31.11% to $3.5 million in 2026.
• Business Quant data shows SRTA's Operating Leases at $3.5 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.